Global In Vivo Contract Research Organization Market Forecast 2026–2035: Long-Term Growth Insights
Uncover key drivers, emerging technologies, and competitive movements shaping the in vivo contract research organization market from 2026–2035 with trusted insights from The Business Research Company
What market expansion outlook does the In Vivo Contract Research Organization Market show for the 2026–2030 period?
The in vivo contract research organization market size has experienced substantial growth in recent years. This market is projected to expand from $5.23 billion in 2025 to $5.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. Historically, this expansion has been driven by increasing pharmaceutical research and development spending, the broadening of biotechnology pipelines, the rising complexity of drug development, stricter regulatory requirements for preclinical data, and the availability of advanced animal models.
The in vivo contract research organization market size is projected to experience robust expansion over the coming years. By 2030, its valuation is anticipated to reach $7.77 billion, demonstrating a compound annual growth rate (CAGR) of 8.1%. This anticipated growth during the forecast period stems from factors such as a heightened demand for expedited drug development, the expanding application of sophisticated in vivo disease models, the widening scope of oncology and rare disease investigations, the increasing integration of AI-powered preclinical analytics, and more stringent regulatory oversight concerning safety data. Key trends emerging within the forecast timeframe encompass the rising propensity to outsource preclinical research, a greater need for specialized disease models, an increase in GLP-compliant toxicology studies, the broadening of integrated preclinical service portfolios, and a reinforced emphasis on the quality and replicability of data.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25790&type=smp
What Drivers Are Shaping The Development Of The In Vivo Contract Research Organization Market?
The increasing emphasis on personalized medicine is anticipated to fuel the expansion of the in vivo contract research organization market in the future. Personalized medicine represents a medical strategy that customizes treatment and prevention approaches according to an individual’s genetic makeup, lifestyle, and environment to optimize health outcomes. This heightened focus on personalized medicine is driven by the improved accessibility and affordability of genomic sequencing technologies, as these advancements enable more accurate identification of genetic mutations, which in turn leads to tailored therapies that enhance patient results and minimize trial-and-error in treatment. Consequently, the growing attention to personalized medicine is stimulating demand in the in vivo CRO market, given the necessity for customized preclinical studies using specific animal models to evaluate targeted therapies and their effects on distinct genetic profiles. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the FDA approved 16 new personalized treatments in 2023, an increase from six in 2022. Personalized medicines accounted for more than one-third of all new drug approvals by the U.S. Food and Drug Administration (FDA) for the fourth consecutive year. Therefore, the expanding focus on personalized medicine is a key driver for the growth of the in vivo contract research organization market.
Which Segments Are Contributing To The Growth Of The In Vivo Contract Research Organization Market?
The in vivo contract research organization market covered in this report is segmented –
1) By Type: Rodent Based, Non-Rodent Based
2) By Type Of Service: Translational And IND-Enabling In Vivo Studies, Preclinical Services, Post-Approval Nonclinical Safety And Mechanistic Studies
3) By Good Laboratory Practice Type: Good Laboratory Practice Toxicology, Non Good Laboratory Practice
4) By Applications: Oncology, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Government And Regulatory Bodies
Subsegments:
1) By Rodent-Based: Mice Models, Rat Models, Genetically Engineered Rodents, Immunodeficient Rodents, Humanized Rodents
2) By Non-Rodent-Based: Canine Models, Non-Human Primate Models, Swine Models, Rabbit Models, Zebrafish Models
What Long-Term Trends Are Expected To Shape The Future Of The In Vivo Contract Research Organization Market?
Major companies within the in vivo contract research organization market are prioritizing the creation of novel solutions, including advanced therapy incubator programs, to hasten the progression of next-generation therapeutics and support early-phase clinical investigations. An advanced therapy incubator program serves as a specialized endeavor designed to assist early-stage biotechnology companies by offering resources, mentorship, and infrastructure to accelerate the development of advanced therapies such as gene, cell, and RNA-based treatments. For instance, in April 2025, Charles River Laboratories International Inc., a US-based pharmaceutical company, introduced its inaugural advanced therapy incubator program cohort. This innovative undertaking is crafted to support nascent biotech companies focused on advancing next-generation therapies. Through this program, participants gain access to Charles River’s scientific knowledge, state-of-the-art laboratory infrastructure, and customized in vivo models, empowering them to rapidly produce proof-of-concept data. The program additionally furnishes a real-world preclinical setting for validating therapeutic candidates, thereby helping to reduce time-to-clinic and improve the prospects of regulatory success. By bridging the divide between academic innovation and clinical development, the initiative plays a vital role in advancing the field of advanced therapies.
Who Are The Major Companies Operating In The In Vivo Contract Research Organization Market?
Major companies operating in the in vivo contract research organization market are Thermo Fisher Scientific Inc, Labcorp Drug Development Inc, Eurofins Scientific SE, WuXi AppTec, Charles River Laboratories International Inc, Evotec SE, GemPharmatech Co Ltd, BIOQUAL Inc, Crown Bioscience Inc, PsychoGenics Inc, Janvier Labs SAS, Taconic Bioscience Inc, Xentech SAS, Altogen Labs Inc, AniLocus Inc, Pharmaron Beijing Co Ltd, Southern Research Institute, SRI International, Envigo RMS LLC, Horizon Discovery Group plc, Inotiv Inc, GenScript ProBio
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The In Vivo Contract Research Organization Market?
North America was the largest region in the in vivo contract research organization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo contract research organization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized In Vivo Contract Research Organization Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25790&type=smp
Browse Through More Reports Similar to the Global In Vivo Contract Research Organization Market 2026, By The Business Research Company
Contract Development Manufacturing Organizations Market Report 2026
Biologics Contract Development Market Report 2026
Medical Device Contract Manufacturing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
